Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence
Alexander O. Pasternak (),
Pien M. Paassen,
Yara L. Verschoor,
Jelmer Vroom,
Karel A. Dort,
Irma Maurer,
Marlous L. Grijsen,
Ferdinand W. Wit,
Godelieve J. Bree,
Neeltje A. Kootstra,
Jan M. Prins and
Ben Berkhout
Additional contact information
Alexander O. Pasternak: University of Amsterdam
Pien M. Paassen: University of Amsterdam
Yara L. Verschoor: University of Amsterdam
Jelmer Vroom: University of Amsterdam
Karel A. Dort: University of Amsterdam
Irma Maurer: University of Amsterdam
Marlous L. Grijsen: Faculty of Medicine Universitas Indonesia
Ferdinand W. Wit: University of Amsterdam
Godelieve J. Bree: University of Amsterdam
Neeltje A. Kootstra: University of Amsterdam
Jan M. Prins: University of Amsterdam
Ben Berkhout: University of Amsterdam
Nature Communications, 2025, vol. 16, issue 1, 1-16
Abstract:
Abstract Initiation of antiretroviral therapy (ART) during primary HIV-1 infection (PHI) has been proposed to limit the formation of HIV-1 reservoirs. However, it remains unknown whether temporary ART initiated during PHI has a long-term effect on viral persistence. Here, we longitudinally quantify HIV-1 persistence markers and immunological parameters in the participants (n = 64) of a randomized controlled trial comparing 24 or 60 weeks of temporary ART vs. no treatment during PHI, who subsequently (re)initiated ART during chronic HIV-1 infection (CHI) after a median period of 116 weeks without treatment (ISRCTN59497461). Levels of several HIV-1 persistence markers (cell-associated unspliced RNA, total DNA, and intact DNA) do not significantly differ and strongly positively correlate between early and CHI ART periods in the same participants. Early ART is associated with lower HIV-1 proviral sequence diversity and superior restoration of the CD4/CD8 ratio, as well as lower levels of monocyte activation markers, compared to CHI ART, in the same participants. At CHI ART, intact HIV-1 DNA negatively correlates with HIV-specific T-cell responses. Finally, levels of HIV-1 persistence markers during CHI ART are lower in participants who had been pre-treated during PHI, indicating a long-term suppressive effect of temporary early ART on the persistence of HIV-1 reservoir.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-62362-0 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62362-0
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-62362-0
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().